LINCS tools
.5 LINCS tools
- LINCS project goal: To understand how alterations in biological processes affect cellular phenotype (molecular, cellular, behavioral, and functional changes) to shed light on disease mechanisms.
- LINCS data availability: Data releases make LINCS data accessible to the public as a community resource, supporting basic research and drug target identification.
- LINCS database content: Includes data from human cell experiments treated with bioactive compounds, ligands, or genetic changes.
- LINCS data types: Assays measure transcript and protein expression, biochemical and imaging data, capturing cellular phenotypic characteristics.
- LINCS project phases: A two-part NIH Common Fund project, with a pilot phase in 2013 focusing on: large-scale molecular and cellular modification signatures, database development for data access, software development and data gathering, and advancements in cost-effective phenotyping.
.5.1 The program’s overall goal
- LINCS aims to understand health and illness by identifying ""cellular signatures"" across various tissues and cells. These signatures represent patterns of common networks and cellular responses.
- The program operates on the principle that changes in any biological process can alter cellular characteristics, behavior, and function.
- Cellular signatures are defined as data descriptors with reduced dimensionality, providing insights and predictive capabilities.
- These signatures are generated by analyzing how various stimuli affect cellular phenotypes.
- The data integration and normalization process is complex, requiring theoretical and practical considerations.
.5.2 Test performed under LINCS
- Drug Toxicity Signature Generation Center: This center focuses on understanding how differentiated iPSCs (induced pluripotent stem cells) respond to medications.
- HMS LINCS Center: This center uses various assays like imaging, transcriptional response tests, cell viability assays, and drug-kinase interaction studies to monitor cellular responses to drugs.
- LINCS Center for Transcriptomics: Collaborates with the HMS LINCS Center to conduct transcriptional response tests.
- Purpose: The overall aim is to develop a comprehensive understanding of how differentiated iPSCs react to medications, ultimately contributing to drug safety assessments.